Please Wait.....
Report
Global Drug modeling software Market - Industry Trends and Forecast to 2030
Market Report I 2023-06-01 I 468 Pages I Data Bridge Market Research
The drug modeling software market is expected to reach USD 16,808.81 million by 2030 from USD 8,504.35 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2033.
Market Segmentation:
Global Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country ( U.S., Canada, Mexico, Germany, France , U.K., Italy, Russia, Spain, Turkey, Netherlands, Switzerland, Belgium,Poland,Sweden, Denmark, Finland, Norway, Rest of Europe, China, Japan , South Korea , India , Australia , Singapore, Thailand , Indonesia , Philippines , Malaysia , New Zealand , Vietnam , Taiwan, Rest Of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa , Saudi Arabia , UAE , Egypt, Israel , Oman , Bahrain , Kuwait , Qatar , Rest of Middle East and Africa - Industry Trends and Forecast to 2030
Overview of Global Drug Modeling Software Market Dynamics :
Driver
- Rising drug discovery and development activities
Restrain
- Lack of quality data base
Opportunity
- Cloud computing and big data analytics in drug modelling
Market Players:
The key market players operating in the drug modeling software market are listed below:
- Dotmatics
- BC Platforms
- InSilicoTrials Technologies.
- VeriSIM Life., Atomwise Inc.
- Certara, USA.
- GENECODE
- Cresset., and Nanome Inc.
- SIMULATIONS PLUS.
- Dassault Systemes
- Scripps Research
- XtalPi Inc.
- Xybion
- ArgusLab
- Schrodinger, Inc.
TABLE OF CONTENTS
1 INTRODUCTION 58
1.1 OBJECTIVES OF THE STUDY 58
1.2 MARKET DEFINITION 58
1.3 OVERVIEW OF THE GLOBAL DRUG MODELING SOFTWARE MARKET 58
1.4 CURRENCY AND PRICING 60
1.5 LIMITATIONS 60
1.6 MARKETS COVERED 60
2 MARKET SEGMENTATION 63
2.1 MARKETS COVERED 63
2.2 GEOGRAPHICAL SCOPE 64
2.3 YEARS CONSIDERED FOR THE STUDY 65
2.4 DBMR TRIPOD DATA VALIDATION MODEL 66
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 69
2.6 MULTIVARIATE MODELING 70
2.7 COMPONENT LIFELINE CURVE 70
2.8 DBMR MARKET POSITION GRID 71
2.9 VENDOR SHARE ANALYSIS 72
2.10 MARKET APPLICATION COVERAGE GRID 73
2.11 SECONDARY SOURCES 74
2.12 ASSUMPTIONS 74
3 EXECUTIVE SUMMARY 75
3.1 PORTER'S FIVE FORCES MODEL 81
3.2 VALUE CHAIN ANALYSIS 82
3.3 REGULATORY STANDARDS 83
3.4 TECHNOLOGICAL TRENDS 84
3.5 BENEFITS OF DRUG MODELING SOFTWARE 85
4 MARKET OVERVIEW 86
4.1 DRIVERS 88
4.1.1 RISING DRUG DISCOVERY AND DEVELOPMENT ACTIVITIES 88
4.1.2 RISING DEMAND FOR NOVEL THERAPIES 90
4.1.3 PRECISION MEDICINE AND INTERVENTION OF AI IN DRUG MODELLING 91
4.2 RESTRAINTS 92
4.2.1 LACK OF QUALITY DATA BASE 92
4.2.2 HIGH COST OF MANUFACTURING OF DRUG MODELLING SOFTWARE 92
4.3 OPPORTUNITIES 93
4.3.1 CLOUD COMPUTING AND BIG DATA ANALYTICS IN DRUG MODELLING 93
4.3.2 INCREASING ADOPTION OF MODELLING TOOLS IN DRUG DISCOVERY 94
4.4 CHALLENGES 94
4.4.1 LACK OF PROCEDURE FOR MULTI-DRUG EFFECT ASSESMENT 94
4.4.2 CHALLENGES WITH MODEL INTERPRETATION 95
5 GLOBAL DRUG MODELING SOFTWARE MARKET, BY COMPONENTS 96
5.1 OVERVIEW 97
5.1.1 SOFTWARE 100
5.1.1.1 INTEGRATED 101
5.1.1.2 STANDALONE 101
5.1.1.3 LIGAND BASED 101
5.1.1.4 STRUCTURE BASED 101
5.2 SERVICES 101
5.2.1 PROFESSIONAL SERVICES 102
5.2.1.1 CONSULTING AND TRAINING 103
5.2.1.2 INTEGRATION AND IMPLEMENTATION 103
5.2.1.3 SUPPORT AND MAINTENANCE 103
5.2.2 MANAGED SERVICES 103
6 GLOBAL DRUG MODELING SOFTWARE MARKET, BY OPERATING SYSTEM 104
6.1 OVERVIEW 105
6.2 WINDOWS 108
6.3 LINUX 108
6.4 MAC OS 109
6.5 OTHERS 110
7 GLOBAL DRUG MODELING SOFTWARE MARKET, BY DEPLOYMENT MODE 111
7.1 OVERVIEW 112
7.2 CLOUD BASED 115
7.3 HYBRID-BASED 115
7.4 ON-PREMISES 116
8 GLOBAL DRUG MODELING SOFTWARE MARKET, BY ENTERPRISE SIZE 117
8.1 OVERVIEW 118
8.2 LARGE ENTERPRISE SIZE 121
8.3 SMALL & MEDIUM ENTERPRISE SIZE 121
9 GLOBAL DRUG MODELING SOFTWARE MARKET, BY APPLICATION 123
9.1 OVERVIEW 124
9.2 GRAPHICAL MOLECULAR MODELING 127
9.3 GENE SEQUENCE ANALYSIS 127
9.4 PROTEIN MODELING 128
9.5 MODELING CRYSTAL STRUCTURES 129
9.6 CHEMINFORMATICS 130
9.7 HIGH THROUGHPUT VIRTUAL SCREENING 131
9.8 GAS & SOLUTION PHASE REACTION 131
9.9 MEDICAL IMAGING 132
9.10 OTHERS 133
10 GLOBAL DRUG MODELING SOFTWARE MARKET, BY PURCHASING MODEL 134
10.1 OVERVIEW 135
10.2 SUBSCRIPTION BASED 138
10.2.1 ANNUALLY SUBSCRIPTION 139
10.2.2 MONTHLY SUBSCRIPTION 139
10.3 ONE-TIME LICENSE 139
10.3.1 GROUP LICENSE 140
10.3.2 DESKTOP LICENSE 140
10.3.3 OTHERS 140
11 GLOBAL DRUG MODELING SOFTWARE MARKET, BY END USER 141
11.1 OVERVIEW 142
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 145
11.2.1 LARGE ENTERPRISE SIZE 146
11.2.2 SMALL & MEDIUM ENTERPRISE SIZE 146
11.3 CONTRACT RESEARCH ORGANIZATIONS 146
11.3.1 LARGE ENTERPRISE SIZE 147
11.3.2 SMALL & MEDIUM ENTERPRISE SIZE 147
11.4 RESEARCH INSTITUTES 147
11.4.1 LARGE ENTERPRISE SIZE 148
11.4.2 SMALL & MEDIUM ENTERPRISE SIZE 148
11.5 REGULATORY AUTHORITIES 148
11.5.1 LARGE ENTERPRISE SIZE 149
11.5.2 SMALL & MEDIUM ENTERPRISE SIZE 150
11.6 OTHERS 150
11.6.1 LARGE ENTERPRISE SIZE 151
11.6.2 SMALL & MEDIUM ENTERPRISE SIZE 151
12 GLOBAL DRUG MODELING SOFTWARE MARKET, BY REGION 152
12.1 OVERVIEW 153
12.2 NORTH AMERICA 159
12.2.1 U.S. 169
12.2.2 CANADA 174
12.2.3 MEXICO 179
12.3 EUROPE 184
12.3.1 GERMANY 195
12.3.2 FRANCE 200
12.3.3 U.K. 205
12.3.4 ITALY 210
12.3.5 RUSSIA 215
12.3.6 SPAIN 220
12.3.7 TURKEY 225
12.3.8 NETHERLANDS 230
12.3.9 SWITZERLAND 235
12.3.10 BELGIUM 240
12.3.11 POLAND 245
12.3.12 SWEDEN 250
12.3.13 DENMARK 255
12.3.14 FINLAND 260
12.3.15 NORWAY 265
12.3.16 REST OF EUROPE 270
12.4 ASIA-PACIFIC 271
12.4.1 CHINA 282
12.4.2 JAPAN 287
12.4.3 SOUTH KOREA 292
12.4.4 INDIA 297
12.4.5 AUSTRALIA 302
12.4.6 SINGAPORE 307
12.4.7 THAILAND 312
12.4.8 INDONESIA 317
12.4.9 PHILIPPINES 322
12.4.10 MALAYSIA 327
12.4.11 NEW ZEALAND 332
12.4.12 VIETNAM 337
12.4.13 TAIWAN 342
12.4.14 REST OF ASIA-PACIFIC 347
12.5 SOUTH AMERICA 348
12.5.1 BRAZIL 359
12.5.2 ARGENTINA 364
12.5.3 REST OF SOUTH AMERICA 369
12.6 MIDDLE EAST AND AFRICA 370
12.6.1 SOUTH AFRICA 380
12.6.2 SAUDI ARABIA 385
12.6.3 U.A.E. 390
12.6.4 EGYPT 395
12.6.5 ISRAEL 400
12.6.6 OMAN 405
12.6.7 BAHRAIN 410
12.6.8 KUWAIT 415
12.6.9 QATAR 420
12.6.10 REST OF MIDDLE EAST AND AFRICA 425
13 GLOBAL DRUG MODELING SOFTWARE MARKET: COMPANY LANDSCAPE 426
13.1 COMPANY SHARE ANALYSIS: GLOBAL 426
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 427
13.3 COMPANY SHARE ANALYSIS: EUROPE 428
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 429
14 SWOT ANALYSIS 430
15 GLOBAL DRUG MODELING SOFTWARE MARKET, COMPANY PROFILE 431
15.1 DASSAULT SYSTEMES 431
15.1.1 COMPANY SNAPSHOT 431
15.1.2 REVENUE ANALYSIS 431
15.1.3 COMPANY SHARE ANALYSIS 432
15.1.4 PRODUCT PORTFOLIO 432
15.1.5 RECENT DEVELOPMENT 432
15.2 AMAZON WEB SERVICES, INC. OR ITS AFFILIATES.(A SUBSIDIARY OF AMAZON) 433
15.2.1 COMPANY SNAPSHOT 433
15.2.2 REVENUE ANALYSIS 433
15.2.3 COMPANY SHARE ANALYSIS 434
15.2.4 PRODUCT PORTFOLIO 434
15.2.5 RECENT DEVELOPMENTS 434
15.3 CERTARA, USA. 435
15.3.1 COMPANY SNAPSHOT 435
15.3.2 REVENUE ANALYSIS 435
15.3.3 COMPANY SHARE ANALYSIS 436
15.3.4 PRODUCT PORTFOLIO 436
15.3.5 RECENT DEVELOPMENTS 436
15.4 SCHRODINGER, INC. 437
15.4.1 COMPANY SNAPSHOT 437
15.4.2 REVENUE ANALYSIS 437
15.4.3 COMPANY SHARE ANALYSIS 438
15.4.4 PRODUCT PORTFOLIO 438
15.4.5 RECENT DEVELOPMENT 438
15.5 CRESSET. 439
15.5.1 COMPANY SNAPSHOT 439
15.5.2 COMPANY SHARE ANALYSIS 439
15.5.3 PRODUCT PORTFOLIO 440
15.5.4 RECENT DEVELOPMENTS 440
15.6 ACELLERA LTD 441
15.6.1 COMPANY SNAPSHOT 441
15.6.2 PRODUCT PORTFOLIO 441
15.6.3 RECENT DEVELOPMENTS 441
15.7 ARGUSLAB 442
15.7.1 COMPANY SNAPSHOT 442
15.7.2 PRODUCT PORTFOLIO 442
15.7.3 RECENT DEVELOPMENT 442
15.8 ATOMWISE INC. 443
15.8.1 COMPANY SNAPSHOT 443
15.8.2 PRODUCT PORTFOLIO 443
15.8.3 RECENT DEVELOPMENT 443
15.9 BC PLATFORMS 444
15.9.1 COMPANY SNAPSHOT 444
15.9.2 PRODUCT PORTFOLIO 444
15.9.3 RECENT DEVELOPMENTS 445
15.10 BIOSOLVEIT GMBH 446
15.10.1 COMPANY SNAPSHOT 446
15.10.2 PRODUCT PORTFOLIO 446
15.10.3 RECENT DEVELOPMENT 446
15.11 DOTMATICS 447
15.11.1 COMPANY SNAPSHOT 447
15.11.2 PRODUCT PORTFOLIO 447
15.11.3 RECENT DEVELOPMENTS 448
15.12 GENECODE 449
15.12.1 COMPANY SNAPSHOT 449
15.12.2 PRODUCT PORTFOLIO 449
15.12.3 RECENT DEVELOPMENT 449
15.13 INSILICOTRIALS TECHNOLOGIES. 450
15.13.1 COMPANY SNAPSHOT 450
15.13.2 PRODUCT PORTFOLIO 450
15.13.3 RECENT DEVELOPMENTS 451
15.14 NANOME INC. 452
15.14.1 COMPANY SNAPSHOT 452
15.14.2 PRODUCT PORTFOLIO 452
15.14.3 RECENT DEVELOPMENT 452
15.15 OPTIBRIUM, LTD. 453
15.15.1 COMPANY SNAPSHOT 453
15.15.2 PRODUCT PORTFOLIO 453
15.15.3 RECENT DEVELOPMENT 453
15.16 PHARMACELERA 454
15.16.1 COMPANY SNAPSHOT 454
15.16.2 PRODUCT PORTFOLIO 454
15.16.3 RECENT DEVELOPMENT 454
15.17 SIMULATIONS PLUS. 455
15.17.1 COMPANY SNAPSHOT 455
15.17.2 REVENUE ANALYSIS 456
15.17.3 COMPANY SHARE ANALYSIS 457
15.17.4 PRODUCT PORTFOLIO 457
15.17.5 RECENT DEVELOPMENT 458
15.18 THE SCRIPPS RESEARCH INSTITUTE 459
15.18.1 COMPANY SNAPSHOT 459
15.18.2 PRODUCT PORTFOLIO 459
15.18.3 RECENT DEVELOPMENT 459
15.19 VERISIM LIFE. 460
15.19.1 COMPANY SNAPSHOT 460
15.19.2 PRODUCT PORTFOLIO 460
15.19.3 RECENT DEVELOPMENTS 460
15.20 XTALPI INC. 461
15.20.1 COMPANY SNAPSHOT 461
15.20.2 PRODUCT PORTFOLIO 461
15.20.3 RECENT DEVELOPMENT 461
15.21 XYBION DIGITAL INC. 462
15.21.1 COMPANY SNAPSHOT 462
15.21.2 REVENUE ANALYSIS 462
15.21.3 PRODUCT PORTFOLIO 463
15.21.4 RECENT DEVELOPMENT 463
16 QUESTIONNAIRE 464
17 RELATED REPORTS 468
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security